A review on synthetic strategy, molecular pharmacology of indazole derivatives, and their future perspective.
SARs
analgesic
anti-inflammatory
anticancer
benzopyrazole
indazole
tautomers
Journal
Drug development research
ISSN: 1098-2299
Titre abrégé: Drug Dev Res
Pays: United States
ID NLM: 8204468
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
revised:
04
07
2022
received:
23
04
2022
accepted:
22
07
2022
pubmed:
17
8
2022
medline:
26
11
2022
entrez:
16
8
2022
Statut:
ppublish
Résumé
With different nitrogen-containing heterocyclic moieties, Indazoles earn one of the places among the top investigated molecules in medicinal research. Indazole, an important fused aromatic heterocyclic system containing benzene and pyrazole ring with a chemical formula of C
Substances chimiques
Indazoles
0
Antineoplastic Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1469-1504Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Aanandhi, M. V., Joseph, A. A., Chandrakumar, R., Koilraj, M., Sujatha, R., & Shanmugasundaram, P. (2016). Synthesis and biological activities of a novel series of indazole derivatives. Biosciences Biotechnology Research Asia, 5, 313-318.
Abbassi, N., Rakib, E. M., Chicha, H., Bouissane, L., Hannioui, A., Aiello, C., Gangemi, R., Castagnola, P., Rosano, C., & Viale, M. (2014). Synthesis and antitumor activity of some substituted indazole derivatives. Archiv der Pharmazie, 347, 423-431. https://doi.org/10.1002/ardp.201300390
Abed, H. B., Schoene, J., Christmann, M., & Nazaré, M. (2016). Organophosphorus-mediated N-N bond formation: Facile access to 3-amino-2 H-indazoles. Organic and Biomolecular Chemistry, 14, 8520-8528. https://doi.org/10.1039/C6OB01544A
Abouzid, K. A., & El-Abhar, H. S. (2003). Synthesis and antiinflammatory activity of novel indazolones. Archives of Pharmacal Research, 26, 1-8. https://doi.org/10.1007/bf03179922
Aghazadeh Tabrizi, M., Baraldi, P. G., Baraldi, S., Gessi, S., Merighi, S., & Borea, P. A. (2017). Medicinal chemistry, pharmacology, and clinical implications of TRPV1 receptor antagonists. Medicinal Research Reviews, 37, 936-983. https://doi.org/10.1002/med.21427
Akay, M., Funingana, I. G., Patel, G., Mustapha, R., Gjafa, E., Ng, T., Ng, K., & Flynn, M. J. (2021). An in-depth review of niraparib in ovarian cancer: Mechanism of action, clinical efficacy and future directions. Oncology and Therapy, 9, 347-364. https://doi.org/10.1007/s40487-021-00167-z
Ali, Z., Ferreira, D., Carvalho, P., Avery, M. A., & Khan, I. A. (2008). Nigellidine-4-O-sulfite, the first sulfated indazole-type alkaloid from the seeds of Nigella sativa. Journal of Natural Products, 71, 1111-1112. https://doi.org/10.1021/np800172x
Andorsky, D. J., Kolibaba, K. S., Assouline, S., Forero-Torres, A., Jones, V., Klein, L. M., Patel-Donnelly, D., Smith, M., Ye, W., Shi, W., & Yasenchak, C. A. (2019). An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma. British Journal of Haematology, 184, 215-222. https://doi.org/10.1111/bjh.15552
Arán, V. J., Stud, M., Foces-Foces, C., Cano, F. H., & Martínez-Ripoll, M. (1985). Synthesis of indazole derivatives from a N, N-disubstituted 2-halobenzoic hydrazide. Crystal structure of 1, 2-pentamethylene-5-nitro-1, 2-dihydro-3H-indazol-3-one. Journal of Heterocyclic Chemistry, 22, 1743-1745. https://doi.org/10.1002/jhet.5570220655
Ardini, E., Menichincheri, M., Banfi, P., Bosotti, R., De Ponti, C., Pulci, R., Ballinari, D., Ciomei, M., Texido, G., Degrassi, A., & Avanzi, N. (2016). Entrectinib, a Pan-TRK, ROS1, and ALK inhibitor with activity in multiple molecularly defined cancer indications. Molecular Cancer Therapeutics, 15, 628-639. https://doi.org/10.1158/1535-7163.MCT-15-0758
Arrouchi, H., Lakhlili, W., & Ibrahimi, A. (2019). A review on PIM kinases in tumors. Bioinformation, 15, 40-45. https://doi.org/10.6026/97320630015040
Atta-UR-Rahman, A. U., Malik, S., Hasan, S. S., Choudhary, M. I., Ni, C. Z., & Clardy, J. (1995). Nigellidine-A new indazole alkaloid from the seeds of Nigella sativa. ChemInform, 26, 30.
Baddam, S. R., Kumar, N. U., Reddy, A. P., & Bandichhor, R. (2013). Regioselective methylation of indazoles using methyl 2, 2, 2-trichloromethylacetimidate. Tetrahedron Letters, 54, 1661-1663. https://doi.org/10.1016/j.tetlet.2013.01.030
Balfour, J. A., & Clissold, S. P. (1990). Bendazac lysine. Drugs, 39, 575-596. https://doi.org/10.2165/00003495-199039040-00007
Banerjee, T., Aggarwal, M., Sommers, J. A., Brosh, R. M., Jr. (2016). Biochemical and cell biological assays to identify and characterize DNA helicase inhibitors. Methods, 108, 130-141. https://doi.org/10.1016/j.ymeth.2016.04.007
Batt, D. G., Petraitis, J. J., Houghton, G. C., Modi, D. P., Cain, G. A., Corjay, M. H., Mousa, S. A., Bouchard, P. J., Forsythe, M. S., Harlow, P. P., & Barbera, F. A. (2000). Disubstituted indazoles as potent antagonists of the integrin αvβ3. Journal of Medicinal Chemistry, 43, 41-58. https://doi.org/10.1021/jm990049j
Bellesoeur, A., Carton, E., Alexandre, J., Goldwasser, F., & Huillard, O. (2017). Axitinib in the treatment of renal cell carcinoma: Design, development, and place in therapy. Drug Design, Development and Therapy, 11, 2801-2811. https://doi.org/10.2147/dddt.s109640
Bharali, P., Tina, M., Mahanta, D., Kalita, M. C., & Das, A. K. (2019). Phytoconstituent evaluation of Pyrus pashia Buch.-Ham. ex D. Don-A potential ethnomedicinal plant from Arunachal Pradesh, India. Current Science, 113(7), 1434-1439. https://doi.org/10.26679/Pleione.13.2.2019.284-290
Billio, A., Morello, E., & Clarke, M. J. (2010). Serotonin receptor antagonists for highly emetogenic chemotherapy in adults. Cochrane Database of Systematic Reviews, (1), CD006272. https://doi.org/10.1002/14651858.cd006272.pub2
Buchanan, D., & Muirhead, K. (2007). Use Intractable nausea and vomiting successfully related with granisetron 5-hydroxtrytamine type 3 receptor antagonists in Palliative Medicine. Palliative Medicine, 21, 725-726. https://doi.org/10.1177/0269216307083383
Cahn, A., Hamblin, J. N., Robertson, J., Begg, M., Jarvis, E., Wilson, R., Dear, G., Leemereise, C., Cui, Y., Mizuma, M., & Montembault, M. (2021). An inhaled PI3Kδ inhibitor improves recovery in acutely exacerbating COPD patients: A randomized trial. International Journal of Chronic Obstructive Pulmonary Disease, 16, 1607. https://doi.org/10.2147/copd.s309129
Cai, S., Lin, S., Yi, X., & Xi, C. (2017). Substrate-controlled transformation of azobenzenes to indazoles and indoles via rh (III)-catalysis. Journal of Organic Chemistry, 82, 512-520. https://doi.org/10.1021/acs.joc.6b02548
Cao, Y., Luo, C., Yang, P., Li, P., & Wu, C. (2021). Indazole scaffold: A generalist for marketed and clinical drugs. Medicinal Chemistry Research, 30, 501-518. https://doi.org/10.1007/s00044-020-02665-7
Catalan, J., & Elguero, J. (1987). Basicity and acidity of azoles. Advances in Heterocyclic Chemistry, 41, 187-274. https://doi.org/10.1016/S0065-2725(08)60162-2
Catalan, J., del Valle, J. C., Claramunt, R. M., Boyer, G., Laynez, J., Gomez, J., Jimenez, P., Tomas, F., & Elguero, J. (1994). Acidity and basicity of indazole and its N-methyl derivatives in the ground and in the excited state. Journal of Physical Chemistry, 98, 10606-10612. https://doi.org/10.1021/j100092a035
Catalán, J., de Paz, J. L., & Elguero, J. (1996). Importance of aromaticity on the relative stabilities of indazole annular tautomers: An ab initio study. Journal of the Chemical Society, Perkin Transactions, 2, 57-60. https://doi.org/10.1039/P29960000057
Cazzola, M., Coppola, A., Rogliani, P., & Matera, M. G. (2015). Novel glucocorticoid receptor agonists in the treatment of asthma. Expert Opinion on Investigational Drugs, 24, 1473-1482. https://doi.org/10.1517/13543784.2015.1078310
Chabukswar, A., Kuchekar, B., Lokhande, P., Tryambake, M., Pagare, B., Kadam, V., Jagdale, S., & Chabukswar, V. (2013). Design, synthesis and evaluation of antibacterial activity of novel indazole derivatives. Current Bioactive Compounds, 9, 263-269.
Chamakuri, K., Muppavarapu, S. M., & Yellu, N. R. (2016). Synthesis and analgesic and anti-inflammatory activities of 7-azaindazole chalcone derivatives. Medicinal Chemistry Research, 25(10), 2392-2398. https://doi.org/10.1007/s00044-016-1671-2
Chamberlain, F. E., Wilding, C., Jones, R. L., & Huang, P. (2019). Pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma. Expert Opinion on Investigational Drugs, 28, 505-511. https://doi.org/10.1080/13543784.2019.1607291
Cheekavolu, C., & Muniappan, M. (2016). In vivo and in vitro anti-inflammatory activity of indazole and its derivatives. Journal of Clinical and Diagnostic Research, 10, FF01. https://doi.org/10.7860/jcdr/2016/19338.8465
Chen, C. Y., Tang, G., He, F., Wang, Z., Jing, H., & Faessler, R. (2016). A synthesis of 1 H-Indazoles via a Cu (OAc) 2-catalyzed N-N bond formation. Organic Letters, 18, 1690-1693. https://doi.org/10.1021/acs.orglett.6b00611
Chen, G., Hu, M., & Peng, Y. (2018). Switchable synthesis of 3-Substituted 1 H-Indazoles and 3, 3-Disubstituted 3 H-Indazole-3-phosphonates tuned by phosphoryl groups. Journal of Organic Chemistry, 83, 1591-1597. https://doi.org/10.1021/acs.joc.7b02857
Chen, Y. (2019). Progress in research on protein tyrosine kinase inhibitors. AIP Conference Proceedings, 2058, 020006. https://doi.org/10.1063/1.5085519
Chen, Y., Tortorici, M. A., Garrett, M., Hee, B., Klamerus, K. J., Pithavala, Y. K. (2013). Clinical pharmacology of axitinib. Clinical Pharmacokinetics, 52, 713-725. https://doi.org/10.1007/s40262-013-0068-3
Cheptea, C., Șunel, V., Stan, C., & Dorohoi, D. O. (2012). New derivatives of 5-nitro-indazole with potential antitumor activity. Revue Roumaine de Chimie, 57, 229.
Cheruvallath, Z. S., Gwaltney, S. L., II, Sabat, M., Tang, M., Wang, H., Jennings, A., Hosfield, D., Lee, B., Wu, Y., Halkowycz, P., & Grimshaw, C. E. (2017). Discovery of potent and orally active 1, 4-disubstituted indazoles as novel allosteric glucokinase activators. Bioorganic & Medicinal Chemistry Letters, 27, 2678-2682. https://doi.org/10.1016/j.bmcl.2017.04.041
Chu, Y. Y., Cheng, H. J., Tian, Z. H., Zhao, J. C., Li, G., Chu, Y. Y., Sun, C. J., & Li, W. B. (2017). Rational drug design of indazole-based diarylurea derivatives as anticancer agents. Chemical Biology & Drug Design, 90, 609-617. https://doi.org/10.1111/cbdd.12984
Counceller, C. M., Eichman, C. C., Wray, B. C., & Stambuli, J. P. (2008). A practical, metal-free synthesis of 1 H-indazoles. Organic Letters, 10, 1021-1023. https://doi.org/10.1021/ol800053f
Crestey, F., Collot, V., Stiebing, S., Lohier, J. F., Sopkova-de Oliveira Santos, J., & Rault, S. (2007). New practical access to 2-azatryptophans and dehydro derivatives via the Wittig-Horner reaction. Tetrahedron Letters, 48, 2457-2460. https://doi.org/10.1016/j.tetlet.2007.02.042
Cui, J., Peng, X., Gao, D., Dai, Y., Ai, J., & Li, Y. (2017). Optimization of 1H-indazol-3-amine derivatives as potent fibroblast growth factor receptor inhibitors. Bioorganic & Medicinal Chemistry Letters, 27, 3782-3786. https://doi.org/10.1016/j.bmcl.2017.06.068
Cui, Y. J., Ma, C. C., Zhang, C. M., Tang, L. Q., & Liu, Z. P. (2020). The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo. European Journal of Medicinal Chemistry, 187, 111968. https://doi.org/10.1016/j.ejmech.2019.111968
Cyr, P., Regnier, S., Bechara, W. S., & Charette, A. B. (2015). Rapid access to 3-aminoindazoles from tertiary amides. Organic Letters, 17, 3386-2289. https://doi.org/10.1021/acs.orglett.5b00765
Denis, C., Sopková-de Oliveira Santos, J., Bureau, R., & Voisin-Chiret, A. S. (2019). Hot-Spots of Mcl-1 protein: Miniperspective. Journal of Medicinal Chemistry, 63, 928-943. https://doi.org/10.1021/acs.jmedchem.9b00983
Dimmito, M. P., Stefanucci, A., Pieretti, S., Minosi, P., Dvorácskó, S., Tömböly, C., Zengin, G., & Mollica, A. (2019). Discovery of orexant and anorexant agents with indazole scaffold endowed with peripheral antiedema activity. Biomolecules, 9, 492. https://doi.org/10.3390/biom9090492
Ditonno, P., Battaglia, M., Selvaggio, O., Garofalo, L., Lorusso, V., & Selvaggi, F. P. (2005). Clinical evidence supporting the role of lonidamine for the treatment of BPH. Reviews in urology, 7, S27-S33.
Dong, J., Zhang, Q., Wang, Z., Huang, G., & Li, S. (2018). Recent advances in the development of indazole-based anticancer agents. Chem Med Chem, 13, 1490-1507. https://doi.org/10.1002/cmdc.201800253
Down, K., Amour, A., Baldwin, I. R., Cooper, A. W., Deakin, A. M., Felton, L. M., Guntrip, S. B., Hardy, C., Harrison, Z. A., Jones, K. L., & Jones, P. (2015). Optimization of novel indazoles as highly potent and selective inhibitors of phosphoinositide 3-kinase δ for the treatment of respiratory disease. Journal of Medicinal Chemistry, 58, 7381-7399. https://doi.org/10.1021/acs.jmedchem.5b00767
Drilon, A. (2019). TRK inhibitors in TRK fusion-positive cancers. Annals of Oncology, 30, 23-30. https://doi.org/10.1093/annonc/mdz282
Du, S., Lu, H., Yang, D., Li, H., Gu, X., Wan, C., Jia, C., Wang, M., Li, X., & Qin, Z. (2015). Synthesis, antifungal activity and QSAR of some novel carboxylic acid amides. Molecules, 20, 4071-4087. https://doi.org/10.3390/molecules20034071
El Aali, N. M. (2018). GC/mass analysis of Adiantium capillus veneris Linn. Acta Scientific Microbiology, 1, 30-44.
Elguero, J., Alkorta, I., Claramunt, R. M., Cabildo, P., Cornago, P., Farrán, M., García, M., López, C., Pérez-Torralba, M., María, D. S., & Sanz, D. (2013). Structure of NH-benzazoles (1H-benzimidazoles, 1H-and 2H-indazoles, 1H-and 2H-benzotriazoles). Chemistry of Heterocyclic Compounds, 49, 177-202. https://doi.org/10.1007/s10593-013-1237-x
El-Hawash, S. A., Badawey, E. S., & El-Ashmawey, I. M. (2006). Nonsteroidal antiinflammatory agents-part 2 antiinflammatory, analgesic and antipyretic activity of some substituted 3-pyrazolin-5-ones and 1, 2, 4, 5, 6, 7-3H-hexahydroindazol-3-ones. European Journal of Medicinal Chemistry, 41, 155-165. https://doi.org/10.1016/j.ejmech.2005.09.006
Elsayed, N. M., Abou El Ella, D. A., Serya, R. A., Tolba, M. F., Shalaby, R., & Abouzid, K. A. (2016). Design, synthesis and biological evaluation of indazole-pyrimidine based derivatives as anticancer agents with anti-angiogenic and antiproliferative activities. MedChemComm, 7(5), 881-899. https://doi.org/10.1039/C5MD00602C
Evans, T. C., Levy, B. R., & Szabocsik JO, J. O. (1993). Clinical study of bendazac lysine for in vivo contact lens cleaning. Optometry and Vision Science, 70, 210-215. https://doi.org/10.1097/00006324-199303000-00007
Fahy, W., Homayoun-Valiani, F., Cahn, A., Robertson, J., Templeton, A., Meeraus, W., Wilson, R., Lowings, M., Marotti, M., Tabberer, M., & West, S. (2019). Nemiralisib in patients experiencing an acute exacerbation of COPD: Design of a double-blind, randomized, placebo-controlled, dose-ranging phase IIb study, C32. COPD: Translational and mechanistic studies (p. A4523). American Thoracic Society.
Fanaki, N. H., & El-Nakeeb, M. A. (1992). Antimicrobial activity of benzydamine, a non-steroid anti-inflammatory agent. Journal of Chemotherapy, 4, 347-352. https://doi.org/10.1080/1120009x.1992.11739190
Farooqi, A. A., & Siddik, Z. H. (2015). Platelet-derived growth factor (PDGF) signalling in cancer: Rapidly emerging signalling landscape. Cell Biochemistry and Function, 33, 257-265. https://doi.org/10.1002/cbf.3120
Farooqui, M., Ali, N. A., Zaheer, Z., Rahman, Z. U., & Khan, A. (2010). Synthesis, anti-bacterial, analgesic and anti-inflammatory activities of some new biologically important indazole derivatives. International Journal of Drug Design & Discovery, 1, 314-324.
Ferguson, H. R., Smith, M. P., & Francavilla, C. (2021). Fibroblast growth factor receptors (FGFRs) and noncanonical partners in cancer signaling. Cells, 10, 1201. https://doi.org/10.3390/cells10051201
Gaikwad, D. D., Abed, S., & Pawar, R. P. (2009). Molecular iodine as an efficient catalyst for the synthesis of indazole. International Journal of ChemTech Research, 1, 442-445.
Gaikwad, D. D., Chapolikar, A. D., Devkate, C. G., Warad, K. D., Tayade, A. P., Pawar, R. P., & Domb, A. J. (2015). Synthesis of indazole motifs and their medicinal importance: An overview. European Journal of Medicinal Chemistry, 90, 707-731. https://doi.org/10.1016/j.ejmech.2014.11.029
Ge, Y., Zhang, Y., Li, X., Yu, Y., & Liu, Q. (2019). Pharmacokinetics and metabolism of H3B-6545, a selective estrogen receptor covalent antagonist, in dog plasma by liquid chromatography combined with electrospray ionization tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 172, 189-199. https://doi.org/10.1016/j.jpba.2019.04.045
Gein, V. L., Yankin, A. N., Nosova, N. V., Levandovskaya, E. B., Novikova, V. V., & Rudakova, I. P. (2019). Synthesis and biological activity of 4, 5, 6, 7-tetrahydro-2H-indazole derivatives. Russian Journal of General Chemistry, 89, 1169-1176.
Gerpe, A., Aguirre, G., Boiani, L., Cerecetto, H., González, M., Olea-Azar, C., Rigol, C., Maya, J. D., Morello, A., Piro, O. E., & Arán, V. J. (2006). Indazole N-oxide derivatives as antiprotozoal agents: Synthesis, biological evaluation and mechanism of action studies. Bioorganic and Medicinal Chemistry, 14, 3467-3480. https://doi.org/10.1016/j.bmc.2006.01.007
Giannouli, V., Kostakis, I. K., Pouli, N., Marakos, P., Kousidou, O. C., Tzanakakis, G. N., & Karamanos, N. K. (2007). Design synthesis, and evaluation of the antiproliferative activity of a series of novel fused xanthenone amino derivatives in human breast cancer cells. Journal of Medicinal Chemistry, 50, 1716-1719. https://doi.org/10.1021/jm061410m
Goodyear, A., Linghu, X., Bishop, B., Chen, C., Cleator, E., McLaughlin, M., Sheen, F. J., Stewart, G. W., Xu, Y., & Yin, J. (2012). Process development and large-scale synthesis of MK-6186, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV. Organic Process Research & Development, 16, 605-611. https://doi.org/10.1021/op200334x
Gross-Goupil, M., Françlois, L., Quivy, A., & Ravaud, A. (2013). Axitinib: A review of its safety and efficacy in the treatment of adults with advanced renal cell carcinoma. Clinical Medicine Insights: Oncology, 7, S10594. https://doi.org/10.4137/cmo.s10594
Haile, P. A., Votta, B. J., Marquis, R. W., Bury, M. J., Mehlmann, J. F., Singhaus, R., Jr., Charnley, A. K., Lakdawala, A. S., Convery, M. A., Lipshutz, D. B., & Desai, B. M. (2016). The identification and pharmacological characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1 H-indazol-3-yl) quinolin-4-amine (GSK583), a highly potent and selective inhibitor of RIP2 kinase. Journal of Medicinal Chemistry, 59, 4867-4880. https://doi.org/10.1021/acs.jmedchem.6b00211
Hari, Y., Shoji, Y., & Aoyama, T. (2005). Regioselective synthesis of 1-arylindazoles via N-arylation of 3-trimethylsilylindazoles. Tetrahedron Letters, 46, 3771-3774. https://doi.org/10.1016/j.tetlet.2005.03.157
Hari, Y., Sone, R., & Aoyama, T. (2009). Facile two-step synthesis of 3-substituted indazoles using diazo (trimethylsilyl) methylmagnesium bromide. Organic and Biomolecular Chemistry, 7, 2804-2808. https://doi.org/10.1039/B907796K
Harris, P. A., Boloor, A., Cheung, M., Kumar, R., Crosby, R. M., Davis-Ward, R. G., Epperly, A. H., Hinkle, K. W., Hunter, R. N., III, Johnson, J. H., & Knick, V. B. (2008). Discovery of 5-[[4-[(2, 3-dimethyl-2 H-indazol-6-yl) methylamino]-2-pyrimidinyl] amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor. Journal of Medicinal Chemistry, 51, 4632-4640. https://doi.org/10.1021/jm800566m
Hase, G. J., Deshmukh, K. K., Pokharkar, R. D., Gaje, T. R., & Phatanagre, N. D. (2017). Phytochemical studies on Nerium oleander L. using GC-MS. International Journal of Pharmacognosy and Phytochemical Research, 9, 885-891. https://doi.org/10.25258/phyto.v9i6.8195
Hemmerling, M., Edman, K., Lepistö, M., Eriksson, A., Ivanova, S., Dahmén, J., Rehwinkel, H., Berger, M., Hendrickx, R., Dearman, M., & Jensen, T. J. (2016). Discovery of indazole ethers as novel, potent, non-steroidal glucocorticoid receptor modulators. Bioorganic & Medicinal Chemistry Letters, 26, 5741-5748. https://doi.org/10.1016/j.bmcl.2016.10.052
Henley, Z. A., Bax, B. D., Inglesby, L. M., Champigny, A., Gaines, S., Faulder, P., Le, J., Thomas, D. A., Washio, Y., & Baldwin, I. R. (2017). From PIM1 to PI3Kδ via GSK3β: Target hopping through the Kinome. ACS Medicinal Chemistry Letters, 8, 1093-1098. https://doi.org/10.1021/acsmedchemlett.7b00296
Hodos̆ĕk, M., Kocjan, D., & Hadzi, D. (1988). Ab initio calculations on the hydration of dimethylpyrazole and indazole. Solvent effects on tautomeric energies. Journal of Molecular Structure: THEOCHEM, 165, 115-124. https://doi.org/10.1016/0166-1280(88)87010-6
Honore, P., Chandran, P., Hernandez, G., Gauvin, D. M., Mikusa, J. P., Zhong, C., Joshi, S. K., Ghilardi, J. R., Sevcik, M. A., Fryer, R. M., & Segreti, J. A. (2009). Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia. Pain, 142, 27-35. https://doi.org/10.1016/j.pain.2008.11.004
Hoyt, S. B., Taylor, J., London, C., Ali, A., Ujjainwalla, F., Tata, J., Struthers, M., Cully, D., Wisniewski, T., Ren, N., & Bopp, C. (2017). Discovery of indazole aldosterone synthase (CYP11B2) inhibitors as potential treatments for hypertension. Bioorganic & Medicinal Chemistry Letters, 27, 2384-2388. https://doi.org/10.1016/j.bmcl.2017.04.021
Hu, J., Cheng, Y., Yang, Y., & Rao, Y. (2011). A general and efficient approach to 2 H-indazoles and 1 H-pyrazoles through copper-catalyzed intramolecular N-N bond formation under mild conditions. Chemical Communications, 47, 10133-10135. https://doi.org/10.1039/C1CC13908H
Hu, W., Yu, J. T., Liu, S., Jiang, Y., & Cheng, J. (2017). Copper-mediated annulation of 2-(1-arylvinyl) anilines and aryl nitrosos towards 2, 3-diaryl-2 H-indazoles. Organic Chemistry Frontiers, 4, 22-25. https://doi.org/10.1039/C6QO00540C
Hurst, R., Rollema, H., & Bertrand, D. (2013). Nicotinic acetylcholine receptors: From basic science to therapeutics. Pharmacology and Therapeutics, 137, 22-54. https://doi.org/10.1016/j.pharmthera.2012.08.012
Ikeda, Y., Takano, N., Matsushita, H., Shiraki, Y., Koide, T., Nagashima, R., Fujimura, Y., Shindo, M., Suzuki, S., & Iwasaki, T. (1979). Pharmacological studies on a new thymoleptic antidepressant, 1-[3-(dimethylamino) propyl]-5-methyl-3-phenyl-1H-indazole (FS-32). Arzeneimittel-Forschung, 29, 511-520.
Jagasia, M., Lazaryan, A., Bachier, C. R., Salhotra, A., Weisdorf, D. J., Zoghi, B., Essell, J., Green, L., Schueller, O., Patel, J., & Zanin-Zhorov, A. (2021). ROCK2 inhibition with belumosudil (KD025) for the treatment of chronic graft-versus-host disease. Journal of Clinical Oncology, 39, 1888-1898. https://doi.org/10.1200/JCO.20.02754
Janardhanan, J. C., Mishra, R. K., Das, G., Sini, S., Jayamurthy, P., Suresh, C. H., Praveen, V. K., Manoj, N., & Babu, B. P. (2018). Functionalizable 1H-indazoles by palladium catalyzed aza-nenitzescu reaction: Pharmacophores to donor-acceptor type multi-luminescent fluorophores. Asian Journal of Organic Chemistry, 7, 2094-2104. https://doi.org/10.1002/ajoc.201800413
Jeong, T., Han, S. H., Han, S., Sharma, S., Park, J., Lee, J. S., Kwak, J. H., Jung, Y. H., & Kim, I. S. (2016). Access to 3-acyl-(2 H)-indazoles via Rh (III)-catalyzed C-H addition and cyclization of azobenzenes with α-keto aldehydes. Organic Letters, 18, 232-235. https://doi.org/10.1021/acs.orglett.5b03368
Jones, P., Storer, R. I., Sabnis, Y. A., Wakenhut, F. M., Whitlock, G. A., England, K. S., Mukaiyama, T., Dehnhardt, C. M., Coe, J. W., Kortum, S. W., & Chrencik, J. E. (2017). Design and synthesis of a pan-Janus kinase inhibitor clinical candidate (PF-06263276) suitable for inhaled and topical delivery for the treatment of inflammatory diseases of the lungs and skin. Journal of Medicinal Chemistry, 60, 767-786. https://doi.org/10.1021/acs.jmedchem.6b01634
Kang, J. M., Kwon, S. O., Ann, J., Blumberg, P. M., Ha, H., Yoo, Y. D., Frank-Foltyn, R., Lesch, B., Bahrenberg, G., Stockhausen, H., & Christoph, T. (2020). Discovery of 1-(1H-indazol-4-yl)-3-((1-phenyl-1H-pyrazol-5-yl) methyl) ureas as potent and thermoneutral TRPV1 antagonists. Bioorganic & Medicinal Chemistry Letters, 30, 127548. https://doi.org/10.1016/j.bmcl.2020.127548
Kasper, B., & Hohenberger, P. (2011). Pazopanib: A promising new agent in the treatment of soft tissue sarcomas. Future Oncology, 7, 1373-13783. https://doi.org/10.2217/fon.11.116
Kawakubo, H., Sone, T., Wakigawa, K., & Narita, T. (1987). Anti-inflammatory, analgesic properties and antipyretic action of 3-aminoindazole derivatives. Yakugaku Zasshi, 107, 28-36. https://doi.org/10.1248/yakushi1947.107.1_28
Keisner, S. V., & Shah, S. R. (2011). Pazopanib. Drugs, 71, 443-454. https://doi.org/10.2165/11588960-000000000-00000
Kerru, N., Gummidi, L., Maddila, S., Gangu, K. K., & Jonnalagadda, S. B. (2020). A review on recent advances in nitrogen-containing molecules and their biological applications. Molecules, 25, 1909. https://doi.org/10.3390/molecules25081909
Kim, H. T., Ha, H., Kang, G., Kim, O. S., Ryu, H., Biswas, A. K., Lim, S. M., Baik, M. H., & Joo, J. M. (2017). Ligand-controlled regiodivergent C−H alkenylation of pyrazoles and its application to the synthesis of indazoles. Angewandte Chemie-International Edition in English, 56, 16262-16266. https://doi.org/10.1002/anie.201709162
Kim, O. S., Jang, J. H., Kim, H. T., Han, S. J., Tsui, G. C., & Joo, J. M. (2017). Synthesis of fluorescent indazoles by palladium-catalyzed benzannulation of pyrazoles with alkynes. Organic Letters, 19, 1450-1453. https://doi.org/10.1021/acs.orglett.7b00410
Kim, S. H., Markovitz, B., Trovato, R., Murphy, B. R., Austin, H., Willardsen, A. J., Baichwal, V., Morham, S., & Bajji, A. (2013). Discovery of a new HIV-1 inhibitor scaffold and synthesis of potential prodrugs of indazoles. Bioorganic & Medicinal Chemistry Letters, 23, 2888-2892. https://doi.org/10.1016/j.bmcl.2013.03.075
Kisseleva, T., Bhattacharya, S., Braunstein, J., & Schindler, C. W. (2002). Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene, 285, 1-24. https://doi.org/10.1016/s0378-1119(02)00398-0
Kleinman, H. K., Kim, K., & Kang, H. (2018). Matrigel uses in cell biology and for the identification of thymosin β4, a mediator of tissue regeneration. Applied Biological Chemistry, 61, 703-708. https://doi.org/10.1007/s13765-018-0400-6
Konicek, B. W., Capen, A. R., Credille, K. M., Ebert, P. J., Falcon, B. L., Heady, G. L., Patel, B. K., Peek, V. L., Stephens, J. R., Stewart, J. A., & Stout, S. L. (2018). Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors. Oncotarget, 9, 13796-13806. https://doi.org/10.18632/oncotarget.24488
Kosciuczuk, E. M., Saleiro, D., Kroczynska, B., Beauchamp, E. M., Eckerdt, F., Blyth, G. T., Abedin, S. M., Giles, F. J., Altman, J. K., & Platanias, L. C. (2016). Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo. Blood: American Society of Hematology, 128, 410-414. https://doi.org/10.1182/blood-2016-02-698704
Kremeyer, B., Lopera, F., Cox, J. J., Momin, A., Rugiero, F., Marsh, S., Woods, C. G., Jones, N. G., Paterson, K. J., Fricker, F. R., & Villegas, A. (2010). A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron, 66, 671-680. https://doi.org/10.1016/j.neuron.2010.04.030
Kuehl, F. A., Jr., & Egan, R. W. (1980). Prostaglandins, arachidonic acid, and inflammation. Science, 210, 978-984. https://doi.org/10.1126/science.6254151
Kumar, M. R., Park, A., Park, N., & Lee, S. (2011). Consecutive condensation, C-N and N-N bond formations: A copper-catalyzed one-pot three-component synthesis of 2 H-indazole. Organic Letters, 13, 3542-3545. https://doi.org/10.1021/ol201409j
Lee, F. Y., Lien, J. C., Huang, L. J., Huang, T. M., Tsai, S. C., Teng, C. M., Wu, C. C., Cheng, F. C., & Kuo, S. C. (2001). Synthesis of 1-benzyl-3-(5'-hydroxymethyl-2'-furyl) indazole analogues as novel antiplatelet agents. Journal of Medicinal Chemistry, 44, 3746-3749. https://doi.org/10.1021/jm010001h
Lee, K. Y., Gowrisankar, S., & Kim, J. N. (2005). Facile synthesis of 2H-indazole derivatives starting from the Baylis-Hillman adducts of 2-cyclohexen-1-one. Tetrahedron Letters, 46, 5387-5591. https://doi.org/10.1016/j.tetlet.2005.05.149
Lee, S. J., Kim, Y. J., Lee, C. S., & Bae, J. (2009). Combined application of camptothecin and the guanylate cyclase activator YC-1: Impact on cell death and apoptosis-related proteins in ovarian carcinoma cell lines. Chemico-Biological Interactions, 181, 185-192. https://doi.org/10.1016/j.cbi.2009.05.013
Lehmann, F., Koolmeister, T., Odell, L. R., & Scobie, M. (2009). A versatile new synthetic route to 1 N-hydroxyindazoles. Organic Letters, 11, 5078-5081. https://doi.org/10.1021/ol902085k
Li, P., Zhao, J., Wu, C., Larock, R. C., & Shi, F. (2011). Synthesis of 3-substituted indazoles from arynes and N-tosylhydrazones. Organic Letters, 13, 3340-3343. https://doi.org/10.1021/ol201086g
Li, P., Wu, C., Zhao, J., Rogness, D. C., & Shi, F. (2012). Synthesis of substituted 1H-indazoles from arynes and hydrazines. Journal of Organic Chemistry, 77, 3149-3158. https://doi.org/10.1021/jo202598e
Lien, J. C., Lee, F. Y., Huang, L. J., Pan, S. L., Guh, J. H., Teng, C. M., & Kuo, S. C. (2002). 1-Benzyl-3-(5 ‘-hydroxymethyl-2 ‘-furyl) indazole (YC-1) derivatives as novel inhibitors against sodium nitroprusside-induced apoptosis. Journal of Medicinal Chemistry, 45, 4947-4949. https://doi.org/10.1021/jm020070b
Liu, D., Offin, M., Harnicar, S., Li, B. T., & Drilon, A. (2018). Entrectinib: An orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors. Therapeutics and Clinical Risk Management, 14, 1247. https://doi.org/10.2147/TCRM.S147381
Liu, J., Peng, X., Dai, Y., Zhang, W., Ren, S., Ai, J., Geng, M., & Li, Y. (2015). Design, synthesis and biological evaluation of novel FGFR inhibitors bearing an indazole scaffold. Organic and Biomolecular Chemistry, 13, 7643-7654. https://doi.org/10.1039/c5ob00778j
Liu, Q., Yan, H., Zheng, X., Fu, L., Bao, Y., Zheng, H., Liu, Z., Zhang, X., & Chen, G. (2021). A novel indazole derivative, compound Cyy-272, attenuates LPS-induced acute lung injury by inhibiting JNK phosphorylation. Toxicology and Applied Pharmacology, 1, 115648. https://doi.org/10.1016/j.taap.2021.115648
Liu, Y. M., Jiang, Y. H., Liu, Q. H., & Chen, B. Q. (2013). Indazole-type alkaloids from the seeds of Nigella glandulifera. Phytochemistry Letters, 6, 556-559. https://doi.org/10.1016/j.phytol.2013.07.002
Locke, K. W., Dunn, R. W., Hubbard, J. W., Vanselous, C. L., Cornfeldt, M., Fielding, S., & Strupczewski, J. T. (1990). HP 818: A centrally acting analgesic with neuroleptic properties. Drug Development Research, 19, 239-256. https://doi.org/10.1002/ddr.430190304
Long, Z., Wang, Z., Zhou, D., Wan, D., & You, J. (2017). Rh (III)-Catalyzed regio-and chemoselective [4+ 1]-annulation of azoxy compounds with diazoesters for the synthesis of 2 H-indazoles: Roles of the azoxy oxygen atom. Organic Letters, 19, 2777-2780. https://doi.org/10.1021/acs.orglett.7b00631
Lu, M., Felock, P. J., Munshi, V., Hrin, R. C., Wang, Y. J., Yan, Y., Munshi, S., McGaughey, G. B., Gomez, R., Anthony, N. J., & Williams, T. M. (2012). Antiviral activity and in vitro mutation development pathways of MK-6186, a novel nonnucleoside reverse transcriptase inhibitor. Antimicrobial Agents and Chemotherapy, 56, 3324-3335. https://doi.org/10.1128/aac.00102-12
Lu, Z. H., & Kang, X. Q. (2019). Effectiveness of advanced nursing care on depression in patients with ovarian cancer: A protocol of systematic review of randomized controlled trial. Medicine, 98(17), e15316. https://doi.org/10.1097/md.0000000000015316
Lukin, K., Hsu, M. C., Fernando, D., & Leanna, M. R. (2006). New practical synthesis of indazoles via condensation of O-fluorobenzaldehydes and their O-methyloximes with hydrazine. Journal of Organic Chemistry, 71, 8166-8172. https://doi.org/10.1021/jo0613784
Luszczak, S., Kumar, C., Sathyadevan, V. K., Simpson, B. S., Gately, K. A., Whitaker, H. C., & Heavey, S. (2020). PIM kinase inhibition: Co-targeted therapeutic approaches in prostate cancer. Signal Transduction and Targeted Therapy, 5, 1-10. https://doi.org/10.1038/s41392-020-0109-y
Malik, S., Hasan, S. S., Choudhary, M. I., Ni, C. Z., & Clardy, J. (1995). Nigellidine-A new indazole alkaloid from the seeds of Nigella sativa. Tetrahedron Letters, 36, 1993-1996. https://doi.org/10.1016/0040-4039(95)00210-4
Modi, S. J., & Kulkarni, V. M. (2019). Vascular endothelial growth factor receptor (VEGFR-2)/KDR inhibitors: medicinal chemistry perspective. Medicine in Drug Discovery, 2, 100009. https://doi.org/10.1016/j.medidd.2019.100009
Mora, E., Guglielmotti, A., Biondi, G., & Sassone-Corsi, P. (2012). Bindarit: An anti-inflammatory small molecule that modulates the NFkB pathway. Cell Cycle, 11, 159-169. https://doi.org/10.4161/cc.11.1.18559
Nasr, M. N., & Said, S. A. (2003). Novel 3, 3a, 4, 5, 6, 7-hexahydroindazole and arylthiazolylpyrazoline derivatives as anti-inflammatory agents. Archiv der Pharmazie, 336, 551-559. https://doi.org/10.1002/ardp.200300796
Nath, K., Guo, L., Nancolas, B., Nelson, D. S., Shestov, A. A., Lee, S. C., Roman, J., Zhou, R., Leeper, D. B., Halestrap, A. P., & Blair, I. A. (2016). Mechanism of antineoplastic activity of lonidamine. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1866, 151-162. https://doi.org/10.1016/j.bbcan.2016.08.001
Niu, Y., Zhou, L., Meng, L., Chen, S., Ma, C., Liu, Z., & Kang, W. (2020). Recent progress on chemical constituents and pharmacological effects of the genus Nigella. Evidence-based Complementary and Alternative Medicine, 2020, 6756835. https://doi.org/10.1155/2020/6756835
Oh, H., Han, S., Pandey, A. K., Han, S. H., Mishra, N. K., Kim, S., Chun, R., Kim, H. S., Park, J., & Kim, I. S. (2018). Synthesis of (2 H)-Indazoles through Rh (III)-catalyzed annulation reaction of azobenzenes with sulfoxonium ylides. Journal of Organic Chemistry, 83, 4070-4077. https://doi.org/10.1021/acs.joc.8b00501
Pal, D., Tripathi, R., Pandey, D. D., & Mishra, P. (2014). Synthesis, characterization, antimicrobial, and pharmacological evaluation of some 2, 5-disubstituted sulfonyl amino 1, 3, 4-oxadiazole and 2-amino-disubstituted 1, 3, 4-thiadiazole derivatives. Journal of Advanced Pharmaceutical Technology & Research, 5, 196-201. https://doi.org/10.4103/2231-4040.143040
Palmer, M. H., & Kennedy, S. M. (1978). The electronic structure of heteroaromatic molecules; ab initio calculations and photoelectron spectra for the aza derivatives of benzo [c] furan, benzo [c] thiophen, N-methyl isoindole and related compounds. J. Mol. Structure, 43, 33-48. https://doi.org/10.1016/0022-2860(77)80021-5
Paul, M. K., & Mukhopadhyay, A. K. (2004). Tyrosine kinase-Role and significance in cancer. International Journal of Medical Sciences, 1, 101-115. https://doi.org/10.7150/ijms.1.101
Pazdur, R., Bready, B., Scalzo, A. J., Brandof, J. E., Close, D. R., Kolbye, S., & Winn, R. J. (1994). Phase II trial of piroxantrone in metastatic gastric adenocarcinoma. Investigational New Drugs, 12, 263-265. https://doi.org/10.1007/bf00873970
Pérez-Villanueva, J., Yépez-Mulia, L., González-Sánchez, I., Palacios-Espinosa, J. F., Soria-Arteche, O., Sainz-Espuñes, T. D., Cerbón, M. A., Rodríguez-Villar, K., Rodríguez-Vicente, A. K., Cortés-Gines, M., & Custodio-Galván, Z. (2017). Synthesis and biological evaluation of 2H-indazole derivatives: Towards antimicrobial and anti-inflammatory dual agents. Molecules, 22, 1864. https://doi.org/10.3390/molecules22111864
Peruncheralathan, S., Khan, T. A., Ila, H., & Junjappa, H. (2004). α-Oxoketene dithioacetals mediated heteroaromatic annulation protocol for benzoheterocycles: An efficient regiocontrolled synthesis of highly substituted and annulated indazoles. Tetrahedron, 60, 3457-3464. https://doi.org/10.1016/j.tet.2004.02.029
Prasad, A. N., & Reddy, B. M. (2013). Cascade synthesis of N-heterocyclic compounds through one-pot MCR over CuII−hydrotalcite catalyst. Current Catalysis, 2, 159-172.
Pryde, D. C., Marron, B. E., West, C. W., Reister, S., Amato, G., Yoger, K., Antonio, B., Padilla, K., Cox, P. J., Turner, J., & Warmus, J. S. (2017). Discovery of a series of indazole TRPA1 antagonists. ACS Medicinal Chemistry Letters, 8, 666-671. https://doi.org/10.1021/acsmedchemlett.7b00140
Puri, K. D., Doggett, T. A., Douangpanya, J., Hou, Y., Tino, W. T., Wilson, T., Graf, T., Clayton, E., Turner, M., Hayflick, J. S., & Diacovo, T. G. (2004). Mechanisms and implications of phosphoinositide 3-kinase δ in promoting neutrophil trafficking into inflamed tissue. Blood, 103, 3448-3456. https://doi.org/10.1182/blood-2003-05-1667
Qian, S., He, T., Wang, W., He, Y., Zhang, M., Yang, L., Li, G., & Wang, Z. (2016). Discovery and preliminary structure-activity relationship of 1H-indazoles with promising indoleamine-2, 3-dioxygenase 1 (IDO1) inhibition properties. Bioorganic and Medicinal Chemistry, 24, 6194-6205. https://doi.org/10.1016/j.bmc.2016.10.003
Qin, J., Cheng, W., Duan, Y. T., Yang, H., & Yao, Y. (2021). Indazole as a privileged scaffold: The derivatives and their therapeutic applications. Anti-Cancer Agents in Medicinal Chemistry, 21, 839-860. https://doi.org/10.2174/1871520620999200818160350
Rani, P., Pal, D., Hegde, R. R., & Hashim, S. R. (2014). Anticancer, anti-inflammatory, and analgesic activities of synthesized 2-(substituted phenoxy) acetamide derivatives. BioMed Research International, 2014, 386473. https://doi.org/10.1155/2014/386473
Reddy, A. V., Gogireddy, S., & Dubey, P. K. (2015). Design, synthesis and characterization of 1 H-pyridin-4-yl-3, 5-disubstituted indazoles and their anti-inflammatory and analgesic activity. Journal of Chemical Sciences, 127, 433-438. https://doi.org/10.1007/s12039-015-0792-3
Rini, B. I., Garrett, M., Poland, B., Dutcher, J. P., Rixe, O., Wilding, G., Stadler, W. M., Pithavala, Y. K., Kim, S., Tarazi, J., & Motzer, R. J. (2013). Axitinib in metastatic renal cell carcinoma: Results of a pharmacokinetic and pharmacodynamic analysis. Journal of Clinical Pharmacology, 53, 491-504. https://doi.org/10.1002/jcph.73
Ripa, L., Edman, K., Dearman, M., Edenro, G., Hendrickx, R., Ullah, V., Chang, H. F., Lepistö, M., Chapman, D., Geschwindner, S., & Wissler, L. (2018). Discovery of a novel oral glucocorticoid receptor modulator (AZD9567) with improved side effect profile. Journal of Medicinal Chemistry, 61, 1785-1799. https://doi.org/10.1021/acs.jmedchem.7b01690
Robichaux, J. P., Elamin, Y. Y., Tan, Z., Carter, B. W., Zhang, S., Liu, S., Li, S., Chen, T., Poteete, A., Estrada-Bernal, A., & Le, A. T. (2018). Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer. Nature Medicine, 24, 638-646. https://doi.org/10.1038/s41591-018-0007-9
Rolfo, C., Ruiz, R., Giovannetti, E., Gil-Bazo, I., Russo, A., Passiglia, F., Giallombardo, M., Peeters, M., & Raez, L. (2015). Entrectinib: A potent new TRK, ROS1, and ALK inhibitor. Expert Opinion on Investigational Drugs, 24, 1493-1500. https://doi.org/10.1517/13543784.2015.1096344
Rosati, O., Curini, M., Marcotullio, M. C., Macchiarulo, A., Perfumi, M., Mattioli, F. Rismondo, L., & Cravotto, G. (2007). Synthesis, docking studies and anti-inflammatory activity of 4, 5, 6, 7-tetrahydro-2H-indazole derivatives. Bioorganic and Medicinal Chemistry, 15, 3463-3473. https://doi.org/10.1016/j.bmc.2007.03.006
Saczewski, F., Hudson, A. L., Tyacke, R. J., Nutt, D. J., Man, J., Tabin, P., & Saczewski, J. (2003). 2-(4, 5-Dihydro-1H-imidazol-2-yl) indazole (indazim) derivatives as selective I2 imidazoline receptor ligands. European Journal of Pharmaceutical Science, 20, 201-208. https://doi.org/10.1016/S0928-0987(03)00182-9
Sahoo, C. R., Paidesetty, S. K., & Padhy, R. N. (2019). Norharmane as a potential chemical entity for development of anticancer drugs. European Journal of Medicinal Chemistry, 162, 752-764. https://doi.org/10.1016/j.ejmech.2018.11.024
Sahoo, J., Sahoo, C. R., Sarangi, P. K., Prusty, S. K., Padhy, R. N., & Paidesetty, S. K. (2020). Molecules with versatile biological activities bearing antipyrinyl nucleus as pharmacophore. European Journal of Medicinal Chemistry, 186, 111911. https://doi.org/10.1016/j.ejmech.2019.111911
Salim, S. A. (2018). Identification of active pharmaceutical ingredients in Thevetia neriifolia Juss Leaf Callus using analysis of GC-MS. Indian Journal of Public Health Research & Development, 9(12), 1019-1023. https://doi.org/10.5958/0976-5506.2018.01982.4
Sandeep Reddy, G., Mohanty, S., Kumar, J., & Venteswar Rao, B. (2018). Synthesis and evaluation of anticancer activity of indazole derivatives. Russian Journal of General Chemistry, 88, 2394-2399. https://doi.org/10.1134/S1070363218110233
Sartore-Bianchi, A., Pizzutilo, E. G., Marrapese, G., Tosi, F., Cerea, G., & Siena, S. (2020). Entrectinib for the treatment of metastatic NSCLC: Safety and efficacy. Expert Review of Anticancer Therapy, 20, 333-341. https://doi.org/10.1080/14737140.2020.1747439
Sather, A. C., Berryman, O. B., & Rebek, J. (2012). Synthesis of fused indazole ring systems and application to nigeglanine hydrobromide. Organic Letters, 14, 1600-1603. https://doi.org/10.1021/ol300303s
Schenone, S., Bruno, O., Ranise, A., Brullo, C., Bondavalli, F., Filippelli, W., Mazzeo, F., Capuano, A., & Falcone, G. (2003). 2-Aryl-3-phenylamino-4, 5-dihydro-2h-benz [g] indazoles with analgesic activity. Il Farmaco, 58, 845-849. https://doi.org/10.1016/S0014-827X(03)00142-3
Schindler, R., Fleischhauer, I., Höfgen, N., Sauer, W., Egerland, U., Poppe, H., Heer, S., Szelenyi, I., Kutscher, B., & Engel, J. (1998). 1, 5-Disubstituted Indazol-3-ols with anti-inflammatory activity. Archiv der Pharmazie, 331, 13-21. https://doi.org/10.1002/(SICI)1521-4184(199801)331
Schmidt, A., Merkel, L., & Eisfeld, W. (2005). Nucleophilic carbenes and pseudo-cross-conjugated mesomeric betaines of indazole starting from analogues of the alkaloid-betaine nigellicine. European Journal of Organic Chemistry, 2005(10), 2124-2130. https://doi.org/10.1002/ejoc.200500032
Schmidt, A., Beutler, A., & Snovydovych, B. (2008). Recent advances in the chemistry of indazoles. European Journal of Organic Chemistry, 2008, 4073-4095. https://doi.org/10.1002/ejoc.200800227
Schoene, J., Bel Abed, H., Schmieder, P., Christmann, M., & Nazaré, M. (2018). A general one-pot synthesis of 2H-Indazoles using an organophosphorus-silane system. Chemistry - A European Journal, 24, 9090-9100. https://doi.org/10.1002/chem.201800763
Scott, L. J. (2017). Niraparib: First global approval. Drugs, 77, 1029-1034. https://doi.org/10.1007/s40265-017-0752-y
Selwood, D. L., Brummell, D. G., Budworth, J., Burtin, G. E., Campbell, R. O., Chana, S. S., Charles, I. G., Fernandez, P. A., Glen, R. C., Goggin, M. C., & Hobbs, A. J. (2001). Synthesis and biological evaluation of novel pyrazoles and indazoles as activators of the nitric oxide receptor, soluble guanylate cyclase. Journal of Medicinal Chemistry, 44, 78-93. https://doi.org/10.1021/jm001034k
Sengel-Turk, C. T., Alcigir, M. E., Ekim, O., Bakar-Ates, F., & Hascicek, C. (2020). Clinicopathological and immunohistochemical evaluation of lonidamine-entrapped lipid-polymer hybrid nanoparticles in treatment of benign prostatic hyperplasia: An experimental rat model. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V, 157, 211-220. https://doi.org/10.1016/j.ejpb.2020.10.016
Solano, L. N., Nelson, G. L., Ronayne, C. T., Jonnalagadda, S., Jonnalagadda, S. K., Kottke, K., Chitren, R., Johnson, J. L., Pandey, M. K., Jonnalagadda, S. C., & Mereddy, V. R. (2020). Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents. Scientific Reports, 10, 1-10.
Song, J. J., & Yee, N. K. (2000). A novel synthesis of 2-aryl-2 H-indazoles via a palladium-catalyzed intramolecular amination reaction. Organic Letters, 2, 519-521. https://doi.org/10.1021/ol990409x
Spiteri, C., Keeling, S., & Moses, J. E. (2010). New synthesis of 1-substituted-1 H-indazoles via 1, 3-dipolar cycloaddition of in situ generated nitrile imines and benzyne. Organic Letters, 12, 3368-3371. https://doi.org/10.1021/ol101150t
Sun, F., Feng, X., Zhao, X., Huang, Z. B., & Shi, D. Q. (2012). An efficient synthesis of 2H-indazoles via reductive cyclization of 2-nitrobenzylamines induced by low-valent titanium reagent. Tetrahedron, 68, 3851-3855. https://doi.org/10.1016/j.tet.2012.03.043
Sun, J. H., Teleha, C. A., Yan, J. S., Rodgers, J. D., & Nugiel, D. A. (1997). Efficient synthesis of 5-(bromomethyl)-and 5-(aminomethyl)-1-THP-indazole. Journal of Organic Chemistry, 62, 5627-5629. https://doi.org/10.1021/jo970375b
Taher, A., Ladwa, S., Rajan, S. T., & Weaver, G. W. (2000). Synthesis of 2-aryl-2H-indazoles by base catalysed reaction of 2-nitrobenzyl triphenylphosphonium bromide and aryl isocyanates. Tetrahedron Letters, 41, 9893-9897. https://doi.org/10.1016/S0040-4039(00)01757-3
Thangadurai, A., Minu, M., Wakode, S., Agrawal, S., & Narasimhan, B. (2012). Indazole: A medicinally important heterocyclic moiety. Medicinal Chemistry Research, 21, 1509-1523. https://doi.org/10.1007/s00044-011-9631-3
Tiwari, S., Mehta, D., Mehta, B. K., & Kumar, P. (2017). Characterization and identification of novel volatile constituents in organic solvent extracts of Syzygium cumini (bark) by GC-MS. Journal of Chemical Sciences, 7, 1250-1256.
Tsujino, H., Uno, T., Yamashita, T., Katsuda, M., Takada, K., Saiki, T., Maeda, S., Takagi, A., Masuda, S., Kawano, Y., & Meguro, K. (2019). Correlation of indoleamine-2, 3-dioxigenase 1 inhibitory activity of 4, 6-disubstituted indazole derivatives and their heme binding affinity. Bioorganic & Medicinal Chemistry Letters, 29, 126607.
Tzanetou, E., Liekens, S., Kasiotis, K. M., Fokialakis, N., & Haroutounian, S. A. (2012). Novel pyrazole and indazole derivatives: Synthesis and evaluation of their anti-proliferative and anti-angiogenic activities. Archiv der Pharmazie, 345, 804-811. https://doi.org/10.1002/ardp.201200057
Tzvetkov, N. T., Stammler, H. G., Neumann, B., Hristova, S., Antonov, L., & Gastreich, M. (2017). Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors. European Journal of Medicinal Chemistry, 127, 470-492. https://doi.org/10.1016/j.ejmech.2017.01.011
Upward, J. W., Arnold, B. D., Link, C., Pierce, D. M., Allen, A., & Tasker, T. C. (1990). The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist. European Journal of Cancer, 26, S12-S15.
Urquhart, L. (2019). FDA new drug approvals in Q3 2019. Nature Reviews. Drug Discovery, 18, 816-817. https://doi.org/10.1038/d41573-019-00177-7
Ushijima, K., Wake, N., Kobayashi, H., Hachisuga, T., Toki, N., Masuzaki, H., Kotera, K., Kawarabayashi, T., Emoto, M., & Kamura, T. (2008). The efficacy and safety of indisetron hydrochloride for the management of nausea/vomiting caused by chemotherapy for gynecologic cancer. Gan To Kagaku Ryoho [Japanese Journal of Cancer and Chemotherapy], 35, 1169-1173.
Wan, Y., He, S., Li, W., & Tang, Z. (2018). Indazole derivatives: Promising anti-tumor agents. Anti-Cancer Agents in Medicinal Chemistry, 18, 1228-1234. https://doi.org/10.2174/1871520618666180510113822
Wan, Y., Li, Y., Yan, C., Wen, J., & Tang, Z. (2020). Discovery of novel indazole-acylsulfonamide hybrids as selective Mcl-1 inhibitors. Bioorganic Chemistry, 104, 104217. https://doi.org/10.1016/j.bioorg.2020.104217
Wang, H. L., Cee, V. J., Chavez, F., Jr., Lanman, B. A., Reed, A. B., Wu, B., Guerrero, N., Lipford, J. R., Sastri, C., Winston, J., & Andrews, K. L. (2015). The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitors. Bioorganic & Medicinal Chemistry Letters, 25, 834-840. https://doi.org/10.1016/j.bmcl.2014.12.068
Wei, W., Wang, Z., Yang, X., Yu, W., & Chang, J. (2017). Divergent synthesis of 1H-Indazoles and 1H-Pyrazoles from hydrazones via iodine-mediated intramolecular aryl and sp3 C-H amination. Advanced Synthesis & Catalysis, 359, 3378-3387. https://doi.org/10.1002/adsc.201700824
Wei, W., Liu, Z., Wu, X., Gan, C., Su, X., Liu, H., Que, H., Zhang, Q., Xue, Q., Yue, L., & Yu, L. (2021). Synthesis and biological evaluation of indazole derivatives as anti-cancer agents. RSC Advances, 11, 15675-15687. https://doi.org/10.1039/D1RA01147B
Wu, C., Fang, Y., Larock, R. C., & Shi, F. (2010). Synthesis of 2 H-Indazoles by the [3+ 2] cycloaddition of arynes and sydnones. Organic Letters, 12, 2234-2237. https://doi.org/10.1021/ol100586r
Xavier, R. J., & Podolsky, D. K. (2007). Unravelling the pathogenesis of inflammatory bowel disease. Nature, 448, 427-434. https://doi.org/10.1038/nature06005
Yakaiah, T., Kurumurthy, C., Lingaiah, B. P., Narsaiah, B., Pamanji, R., Velatooru, L. R., Rao, J. V., Gururaj, S., Parthasarathy, T., & Sridhar, B. (2012). GdCl3 promoted synthesis of novel pyrimidine fused indazole derivatives and their anticancer activity. Medicinal Chemistry Research, 21, 4261-4273. https://doi.org/10.1007/s00044-011-9962-0
Yang, J., Zhou, Q., Chen, H., Wu, L., Zhao, J., Guo, R., Fan, Y., Shi, H., Xue, W., Zhang, P., & Han, H. Z. (2020). Abstract CT127: A phase I study of cMET inhibitor bozitinib in patients with advanced NSCLC harboring cMET alterations. Cancer Research, 80, CT127. https://doi.org/10.1158/1538-7445.AM2020-CT127
Yang, L., Chen, Y., He, J., Njoya, E. M., Chen, J., Liu, S., Xie, C., Huang, W., Wang, F., Wang, Z., & Li, Y. (2019). 4, 6-Substituted-1H-Indazoles as potent IDO1/TDO dual inhibitors. Bioorganic and Medicinal Chemistry, 27, 1087-1098. https://doi.org/10.1016/j.bmc.2019.02.014
Yap, J. L., Chen, L., Lanning, M. E., & Fletcher, S. (2017). Expanding the cancer arsenal with targeted therapies: Disarmament of the antiapoptotic Bcl-2 proteins by small molecules: Miniperspective. Journal of Medicinal Chemistry, 60, 821-838. https://doi.org/10.1021/acs.jmedchem.5b01888
Yeo, E. J., Chun, Y. S., Cho, Y. S., Kim, J., Lee, J. C., Kim, M. S., & Park, J. W. (2003). YC-1: A potential anticancer drug targeting hypoxia-inducible factor 1. Journal of the National Cancer Institute, 95, 516-525. https://doi.org/10.1093/jnci/95.7.516
Yi, X., Jiao, L., & Xi, C. (2016). I 2-Mediated 2 H-indazole synthesis via halogen-bond-assisted benzyl C-H functionalization. Organic and Biomolecular Chemistry, 14, 9912-9918. https://doi.org/10.1039/c6ob01827k
Yuan, T., Nahar, P., Sharma, M., Liu, K., Slitt, A., Aisa, H. A., & Seeram, N. P. (2014). Indazole-type alkaloids from Nigella sativa seeds exhibit antihyperglycemic effects via AMPK activation in vitro. Journal of Natural Products, 77, 2316-2320. https://doi.org/10.1021/np500398m
Zhang, Z., Huang, Y., Huang, G., Zhang, G., & Liu, Q. (2017). [Bis-(trifluoroacetoxy) iodo] benzene-mediated oxidative direct amination C-N bond formation: Synthesis of 1H-Indazoles. Journal of Heterocyclic Chemistry, 54, 2426-2433. https://doi.org/10.1002/jhet.2839
Zhao, C. R., Wang, R. Q., Li, G., Xue, X. X., Sun, C. J., Qu, X. J., & Li, W. B. (2013). Synthesis of indazole based diarylurea derivatives and their antiproliferative activity against tumor cell lines. Bioorganic & Medicinal Chemistry Letters, 23, 1989-1992. https://doi.org/10.1016/j.bmcl.2013.02.034
Zhu, X. Q., Mao, S., Guo, D. D., Li, B., Guo, S. H., Gao, Y. R., & Wang, Y. Q. (2017). Copper-catalyzed isomerization and cyclization of E/Z-o-Haloaryl N-Sulfonylhydrazones: Convenient access to 1H-Indazoles. ChemCatChem, 9, 1084-1091. https://doi.org/10.1002/cctc.201601243
Zoja, C., Corna, D., Locatelli, M., Rottoli, D., Pezzotta, A., Morigi, M., Zanchi, C., Buelli, S., Guglielmotti, A., Perico, N., & Remuzzi, A. (2015). Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney disease. Nephron, 129, 52-61. https://doi.org/10.1159/000369149
ZS, O., Ogunmola, O. O., Kuyooro, S. E., & Abiona, O. O. (2017). Stachytarpheta jamaicensis leaf extract: Chemical composition, antioxidant, anti-arthritic, anti-inflammatory and bactericidal potentials. Journal of Scientific and Innovative Research, 6, 119-125.